Search

everythinglearnresearchcommunity

for

Search:↓

New treatments for hair growth and psoriasis may be possible, and gene differences could affect baldness and the severity of skin conditions.

R-spondin2 may help treat hair loss, gene differences could explain baldness, a peptide's regulation is linked to psoriasis, B-defensin gene copies may affect a skin condition's risk and severity, and potential markers and targets for alopecia areata were identified.

There's a growing resistance to the antibiotic mupirocin in children's skin infections caused by MRSA in New York.

Treatment with biologic agents can significantly improve psoriasis symptoms, and blood biomarkers could potentially predict individual patient's response to treatment.

A 70-year-old woman with a rare skin condition improved after treatment with topical steroids and acitretin.

Adalimumab can cause complete hair loss in rare cases.

Patients with lichen planus should be tested for hepatitis C.

Atopic dermatitis significantly lowers the quality of life for infants and their families.

Female hair loss can be diagnosed using specific trichoscopy criteria.

The document concludes that better targeted treatments are needed for wound healing, and single-cell technologies may improve cell-based therapies.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

Corticosteroids, especially prednisone, improve short-term muscle strength in Duchenne muscular dystrophy but have manageable side effects.

Frontal fibrosing alopecia is a hair loss condition in postmenopausal women, similar to lichen planopilaris, with ineffective treatments.

Changing how mesenchymal stromal cells are grown can improve their healing abilities.

The Rotterdam Study aims to understand disease causes in the elderly and has found new risk factors and genetic influences on various conditions.

The document concludes that the fast-growing direct-to-consumer genetic testing market lacks sufficient regulation, posing risks to consumers due to questionable test quality and accuracy.

Tofacitinib is effective and safe for severe hair loss, but full regrowth is less likely after 10 years of hair loss.

Hidradenitis suppurativa, a chronic skin disease, can be managed with antibiotics, lifestyle changes, and in severe cases, surgery. Early diagnosis and careful planning are key, and laser treatment can be an efficient solution for mild to severe cases.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Two main types of fibroblasts with unique functions and additional subtypes were identified in human skin.

Tofacitinib is safe and effective for severe alopecia areata, but hair loss may return 2 months after stopping treatment.

The ZIP7 gene helps control zinc levels in cells by moving zinc from the Golgi apparatus to the cytoplasm.

Regulatory T-cells are important for healing and regenerating tissues in various organs by controlling immune responses and aiding stem cells.

A patient with Alopecia Areata had complete hair regrowth after using the drug baricitinib.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Demodicosis is common and often missed, needing more recognition and treatment in skin care.

Current treatments for alopecia show no significant long-term benefits.

Stress-related substance P may lead to hair loss and negatively affect hair growth.